AURAAura Biosciences, Inc.

Nasdaq aurabiosciences.com


$ 7.44 $ -0.12 (-1.59 %)    

Friday, 10-May-2024 12:46:24 EDT
QQQ $ 441.89 $ -1.03 (-0.23 %)
DIA $ 395.10 $ -0.16 (-0.04 %)
SPY $ 520.63 $ -0.90 (-0.17 %)
TLT $ 90.00 $ -0.31 (-0.34 %)
GLD $ 219.28 $ -0.50 (-0.23 %)
$ 7.54
$ 7.56
$ 7.52 x 200
$ 0.00 x 0
$ 7.42 - $ 7.60
$ 5.99 - $ 13.50
90,205
na
372.87M
$ 1.32
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-27-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-23-2022 12-31-2021 10-K
11 11-24-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aura-biosciences-fy-2023-eps-193-misses-182-estimate

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(1.93) per share which missed the analyst consensus estimate of $(...

 btig-maintains-buy-on-aura-biosciences-lowers-price-target-to-21

BTIG analyst Robert Hazlett maintains Aura Biosciences (NASDAQ:AURA) with a Buy and lowers the price target from $38 to $21.

 jmp-securities-maintains-market-outperform-on-aura-biosciences-lowers-price-target-to-19

JMP Securities analyst Jonathan Wolleben maintains Aura Biosciences (NASDAQ:AURA) with a Market Outperform and lowers the pr...

 over-13m-bet-on-this-energy-stock-check-out-these-4-stocks-insiders-are-buying

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.

 aura-biosciences-q3-eps-048-beats-052-estimate

Aura Biosciences (NASDAQ:AURA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0....

 why-aura-biosciences-stock-hit-a-new-52-week-low-today

Aura Biosciences Inc (NASDAQ: AURA) shares are trading lower by 34.7% to $7.18 Tuesday afternoon after the company announced pr...

 why-sanmina-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spe...

 why-alteryx-shares-are-trading-higher-by-around-16-here-are-20-stocks-moving-premarket

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reporte...

 sanmina-adtran-ameresco-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures traded lower this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market tradin...

 aura-biosciences-announces-proposed-public-offering-of-common-stock-no-size-or-amount-disclosed

Aura Biosciences, Inc. ("Aura") (NASDAQ:AURA), a clinical-stage biotechnology company developing a novel class of virus...

 aura-biosciences-receives-fda-agreement-under-special-protocol-assessment-for-compass-phase-3-clinical-trial-of-belzupacap-sarotalocan-in-early-stage-choroidal-melanoma

Positive Clinical Efficacy Updates of Bel-sar for Early-Stage Choroidal Melanoma from the Ongoing Phase 2 Clinical Trial with S...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION